| Novel combination of c-myc, N-myc and N-ras oncogene alteration in brain tumors. | brain, |
| Absence of Kirsten-ras oncogene activation in B-cell chronic lymphocytic leukemia. | leukemia, |
| Overexpression of N-ras oncogene and epidermal growth factor receptor gene in human glioblastomas. | glioblastoma, |
| Study of oncogenic potentialities of human melanoma: identification of N-ras oncogene after DNA transfer and tumour induction. | skin, |
| Transforming genes in human leukemia cells. | leukemia, |
| A point mutation at codon 13 of the N-ras oncogene in a human stomach cancer. | gastric, |
| Relapse cell population differs from acute onset clone as shown by absence of the initially activated N-ras oncogene in a patient with acute myelomonocytic leukemia. | leukemia, |
| introducing a rapid and sensitive microarray-based assay for the multiplex detection of minority mutations of oncogenes (KRAS, NRAS and BRAF) with relevant diagnostics implications in tissue biopsies and plasma samples in metastatic colorectal cancer patients | colorectal, |
| The N-ras oncogene in myelodysplastic syndrome and leukemia. | leukemia, |
| Amino-acid substitution at codon 13 of the N-ras oncogene in rectal cancer in a Japanese patient. | colorectal, |
| the neuroblastoma RAS viral oncogene homolog isoforms appear to play varying roles in melanoma phenotype in human cells transplanted into a mouse model | skin,neuroblastoma, |
| Changes in c-myc, c-fms, and N-ras proto-oncogene expression associated with retinoic acid-induced monocytic differentiation of human leukemia HL60/MRI cells. | leukemia, |
| Relationship between an activated N-ras oncogene and chromosomal abnormality during leukemic progression from myelodysplastic syndrome. | leukemia, |
| Mutation analysis of the N-ras proto-oncogene in active and remission phase of human acute leukemias. | leukemia, |
| Glycine-cysteine substitution at codon 13 of the N-ras proto-oncogene in a human T cell non-Hodgkin s lymphoma. | lymphoma, |
| Activation mechanism of the N-ras oncogene in human leukemias detected by synthetic oligonucleotide probes. | leukemia, |
| Association in the expression of Kirsten-ras oncogene and the major histocompatibility complex class I antigens in fibrosarcoma tumor cell variants exhibiting different metastatic capabilities. | fibrosarcoma, |
| Somatic N-ras oncogene activation in a patient with acute myeloblastic leukemia. | leukemia, |
| Expression of the N-ras oncogene in tumorigenic and non-tumorigenic HT 1080 fibrosarcoma X normal human fibroblast hybrid cells. | fibrosarcoma, |
| Methylation of the serum albumin gene as compared to the Kirsten-ras oncogene in hepatocytes and non-parenchymal cells of rat liver. | liver, |